Philippe Camus, M.D.
Dijon, France
XI - Pulmonary vasculopathies
Last update 17/06/2026
May reverse with drug discontinuation. Generally similar to primary PHTn clinically, hemodynamically and on pathology. PMID 23997051. A few cases are thromboembolic in nature (PMID 24881082). Reviews at PMID 29508628, 30545968
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI. Pulmonary vasculopathies
XI.b Acute pulmonary hypertension
XIII. Thrombosis - Embolism
XIII.i Crystal pulmonary embolism
XIII. Thrombosis - Embolism
XIII.k Foreign body pulmonary vasculopathy (Excipient lung disease)
XXII. Acute respiratory/cardiorespiratory failure
XXII.e Respiratory failure from ventilatory depression (of neuromuscular cause or causes)
XXVII. Dyspnea, lone
XXVII.a Dyspnea, unexplained otherwise
XXVII. Dyspnea, lone
XXVII.b Tachypnea
XXXII. Esophageal pathology
XXXII.b Esophageal pathology (erosion, ulcer, tear, rupture, fistula, Boerhaave’s syndrome)
XXXVIII. Miscellaneous - Varia
XXXVIII.d Death following exposure or poisoning
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI. Pulmonary vasculopathies
XI.d Pulmonary hypertension of the newborn (Persistent PHT)
XI. Pulmonary vasculopathies
XI.f Worsening of preexisting PHTn
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XX. Vasculitis
XX.d Vasculitis, pulmonary (w/wo AH), extrathoracic, or systemic: ANCA-positive
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXXIV. Infections
XXXIV.e Tuberculosis (pulmonary, pleural, extrapulmonary or disseminated). Reactivation or de novo)
XXXIV. Infections
XXXIV.f Opportunistic pulmonary/systemic infections
XXXIV. Infections
XXXIV.g Pneumocystis jiroveci pneumonia
XXXIV. Infections
XXXIV.h Nontuberculous pulmonary mycobacterial infection/superinfection
XXXIV. Infections
XXXIV.i Cryptococcus pulmonary and/or systemic infection
XXXIV. Infections
XXXIV.j Viral pneumonia
